Trial Profile
Uncontrolled Lower Respiratory Symptoms in the World Trade Center Survivor Program
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Salmeterol/fluticasone propionate (Primary)
- Indications Respiratory tract disorders
- Focus Therapeutic Use
- 19 Feb 2020 Status changed from active, no longer recruiting to completed.
- 25 Jan 2019 Planned End Date changed from 1 Sep 2018 to 1 Aug 2019.
- 25 Jan 2019 Planned primary completion date changed from 1 Sep 2018 to 1 Aug 2019.